Search research articles
Contact Us
Filters
Showing results (81-90 of 90) with videos related to
Page
of 9
Sort By:
You have reached the last page of results.
This site can display upto 90 results.
ACS Applied Materials & Interfaces
|
April 16, 2025
Effect of Tyrosine-Containing Self-Assembling β-Sheet Peptides on Macrophage Polarization and Inflammatory Response
Jacek K Wychowaniec, Ezgi Irem Bektas, Marcia Muerner, et al.
Anticancer Research
|
October 2, 2019
FOXP3 Inhibitory Peptide P60 Increases Efficacy of Cytokine-induced Killer Cells Against Renal and Pancreatic Cancer Cells
Maria Fitria Setiawan, Oliver Rudan, Annabelle Vogt, et al.
Pain
|
May 21, 2015
Specific changes in conduction velocity recovery cycles of single nociceptors in a patient with erythromelalgia with the I848T gain-of-function mutation of Nav1.7
Barbara Namer, Kristin Ørstavik, Roland Schmidt, et al.
Circulation. Cardiovascular Interventions
|
October 26, 2018
Comparison of Vascular Closure Devices Versus Manual Compression After Femoral Artery Puncture in Women
Senta M Gewalt, Sandra M Helde, Tareq Ibrahim, et al.
Plos One
|
September 7, 2016
SCN10A Mutation in a Patient with Erythromelalgia Enhances C-Fiber Activity Dependent Slowing
Andreas M Kist, Dagrun Sagafos, Anthony M Rush, et al.
Journal of Psychosomatic Research
|
February 6, 2026
Number of group psychotherapy sessions predicts inflammation changes in patients with coronary artery disease and comorbid depression
Joram Ronel, Elisabeth Olliges, Christoph Herrmann-Lingen, et al.
Journal of Pharmaceutical Sciences
|
April 3, 2015
Subvisible (2-100 μm) Particle Analysis During Biotherapeutic Drug Product Development: Part 1, Considerations and Strategy
Linda O Narhi, Vincent Corvari, Dean C Ripple, et al.
Biologicals : Journal of the International Association of Biological Standardization
|
September 2, 2015
Subvisible (2-100 μm) particle analysis during biotherapeutic drug product development: Part 2, experience with the application of subvisible particle analysis
Vincent Corvari, Linda O Narhi, Thomas M Spitznagel, et al.
JAMA
|
November 17, 2014
Comparison of vascular closure devices vs manual compression after femoral artery puncture: the ISAR-CLOSURE randomized clinical trial
Stefanie Schulz-Schüpke, Sandra Helde, Senta Gewalt, et al.
Atmospheric Chemistry and Physics
|
September 24, 2024
A renewed rise in global HCFC-141b emissions between 2017-2021
Luke M Western, Alison L Redington, Alistair J Manning, et al.
Page
of 9
Search research articles
Search
Showing results (81-90 of 90) with videos related to
Sort By:
Page
of 9
You have reached the last page of results.
This site can display upto 90 results.
ACS Applied Materials & Interfaces
|
April 16, 2025
Effect of Tyrosine-Containing Self-Assembling β-Sheet Peptides on Macrophage Polarization and Inflammatory Response
Jacek K Wychowaniec, Ezgi Irem Bektas, Marcia Muerner, et al.
Anticancer Research
|
October 2, 2019
FOXP3 Inhibitory Peptide P60 Increases Efficacy of Cytokine-induced Killer Cells Against Renal and Pancreatic Cancer Cells
Maria Fitria Setiawan, Oliver Rudan, Annabelle Vogt, et al.
Pain
|
May 21, 2015
Specific changes in conduction velocity recovery cycles of single nociceptors in a patient with erythromelalgia with the I848T gain-of-function mutation of Nav1.7
Barbara Namer, Kristin Ørstavik, Roland Schmidt, et al.
Circulation. Cardiovascular Interventions
|
October 26, 2018
Comparison of Vascular Closure Devices Versus Manual Compression After Femoral Artery Puncture in Women
Senta M Gewalt, Sandra M Helde, Tareq Ibrahim, et al.
Plos One
|
September 7, 2016
SCN10A Mutation in a Patient with Erythromelalgia Enhances C-Fiber Activity Dependent Slowing
Andreas M Kist, Dagrun Sagafos, Anthony M Rush, et al.
Journal of Psychosomatic Research
|
February 6, 2026
Number of group psychotherapy sessions predicts inflammation changes in patients with coronary artery disease and comorbid depression
Joram Ronel, Elisabeth Olliges, Christoph Herrmann-Lingen, et al.
Journal of Pharmaceutical Sciences
|
April 3, 2015
Subvisible (2-100 μm) Particle Analysis During Biotherapeutic Drug Product Development: Part 1, Considerations and Strategy
Linda O Narhi, Vincent Corvari, Dean C Ripple, et al.
Biologicals : Journal of the International Association of Biological Standardization
|
September 2, 2015
Subvisible (2-100 μm) particle analysis during biotherapeutic drug product development: Part 2, experience with the application of subvisible particle analysis
Vincent Corvari, Linda O Narhi, Thomas M Spitznagel, et al.
JAMA
|
November 17, 2014
Comparison of vascular closure devices vs manual compression after femoral artery puncture: the ISAR-CLOSURE randomized clinical trial
Stefanie Schulz-Schüpke, Sandra Helde, Senta Gewalt, et al.
Atmospheric Chemistry and Physics
|
September 24, 2024
A renewed rise in global HCFC-141b emissions between 2017-2021
Luke M Western, Alison L Redington, Alistair J Manning, et al.
Page
of 9